Abcam Competitors

Delisted . USA . 
Stock . Abcam PLC
ABCMDelisted Stock  USD 23.59  0.56  2.32%   
Abcam PLC competes with Anebulo Pharmaceuticals, Adagene, Acrivon Therapeutics,, AnaptysBio, and Mineralys Therapeutics,; as well as few others. The company conducts business under Biotechnology sector and is part of Health Care industry. Analyzing Abcam PLC competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Abcam PLC to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Abcam PLC competition on your existing holdings.
  
Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Abcam PLC's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
23.5923.5923.59
Details
Intrinsic
Valuation
LowRealHigh
18.6218.6225.95
Details
Naive
Forecast
LowNextHigh
23.1623.1623.16
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
23.3623.7224.08
Details

Abcam PLC Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Abcam PLC and its competitors represents the degree of relationship between the price movements of corresponding delisted stocks. A correlation of about +1.0 implies that the price of Abcam and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Abcam PLC does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
ACRV
+ 0.77
ADAG
OPT
+ 0.72
MLYS
ANAB
+ 0.66
ANEB
RZLT
+ 0.48
AVTE
RZLT
+ 0.46
ADAG
AVTE
+ 0.44
MLYS
  
High negative correlations   
AVTE
- 0.9
ANAB
AVTE
- 0.66
ANEB
RZLT
- 0.51
ANAB
ANTX
- 0.48
ANEB
ANTX
- 0.31
ANAB
MLYS
- 0.28
ANAB

Risk-Adjusted Indicators

There is a big difference between Abcam Stock performing well and Abcam PLC Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Abcam PLC's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
All Fundamental Data

Abcam PLC Competitive Analysis

The better you understand Abcam PLC competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Abcam PLC's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Abcam PLC's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
ABCM ANEB ADAG ACRV ANAB MLYS AVTE RZLT ANTX OPT
 2.32 
 23.59 
Abcam
 0.70 
 1.44 
Anebulo
 1.30 
 2.34 
Adagene
 0.80 
 7.58 
Acrivon
 0.64 
 24.96 
AnaptysBio
 2.59 
 12.77 
Mineralys
 0.38 
 2.63 
Aerovate
 1.00 
 5.04 
Rezolute
 21.90 
 1.67 
AN2
 10.81 
 3.69 
Opthea
Market Volatility
(90 Days Market Risk)
Very steady
Dangerous
Unstable
Somewhat reliable
Not too volatile
Not too volatile
Somewhat reliable
Unstable
Slightly risky
Moderately volatile
Market Performance
(90 Days Performance)
Very Weak
Very Weak
Very Weak
Very Weak
Very Weak
Insignificant
Good
Insignificant
Good
OK
Odds of Financial Distress
(Probability Of Bankruptcy)
Dangerous
Low
About Average
Low
Low
Low
Low
Low
About Average
High
Current Valuation
(Equity Enterprise Value)
Over Valued
Under Valued
Under Valued
Under Valued
Over Valued
Under Valued
Under Valued
Over Valued
Under Valued
Under Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Strong Buy
Buy
Strong Buy
Strong Buy
Strong Buy
Hold
Strong Buy
Buy
Strong Buy
Trade Advice
(90 Days Macroaxis Advice)
Not Rated
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Buy
Strong Sell
Strong Buy
Strong Sell
Current Ratio
1.26
30.4
3.1
N/A
22.79
N/A
40.85
61.78
28.17
4.97
Net Asset
1.06 B
4.07 M
115.73 M
138.26 M
452.39 M
251.64 M
127.42 M
132.74 M
138.74 M
188.79 M
Profit Margin
0.0066
N/A
N/A
N/A
-2.9
N/A
N/A
N/A
N/A
N/A
EBITDA
42.7 M
(8.05 M)
(14.95 M)
(59.85 M)
(143.16 M)
(84.66 M)
(81.31 M)
(68.42 M)
4.9 M
(200.02 M)
Operating Margin
0.18
N/A
-45.35
N/A
-0.76
N/A
N/A
N/A
N/A
N/A
Current Valuation
5.63 B
35.68 M
27.38 M
50.7 M
345.88 M
655.56 M
(11.96 M)
182.95 M
(54.31 M)
483.28 M
Price To Book
6.04
19.53
1.81
1.19
9.0
2.75
0.95
2.55
0.47
4.31
Retained Earnings
300.7 M
(65.4 M)
(277.75 M)
(116.42 M)
(614.1 M)
(124.71 M)
(163.42 M)
(329.44 M)
(154.46 M)
(579.7 M)
Five Year Return
0.81
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Asset
N/A
N/A
N/A
N/A
297.84 M
N/A
N/A
N/A
N/A
N/A
Beta
0.86
-1.01
0.58
N/A
-0.24
N/A
1.0
1.19
-0.22
1.54
Number Of Employees
1.76 K
2
174
58
117
28
51
59
41
33
Shares Outstanding
230.15 M
25.93 M
44.27 M
31.14 M
30.43 M
49.77 M
28.87 M
57.94 M
29.88 M
153.89 M
Cash Flow From Operations
28.7 M
(8.09 M)
(28.45 M)
(42.64 M)
(120.8 M)
(81.17 M)
(56.78 M)
(57.37 M)
(53.29 M)
(161.02 M)
Annual Yield
0.0075
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Debt
223.9 M
260.58 K
22.31 M
4.64 M
17.81 M
10.48 M
675 K
2.23 M
14.04 M
141.65 M
Return On Equity
0.0035
-1.14
-0.46
-0.38
-1.62
-0.61
-0.82
-0.58
-0.69
-33.83
Z Score
15.73
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return On Asset
0.0436
-0.66
-0.2
-0.24
-0.18
-0.39
-0.49
-0.34
-0.43
-0.83
Number Of Shares Shorted
5.58 M
6.51 K
1.51 K
1.11 M
6.71 M
1.3 M
1.89 M
1.08 M
379.6 K
65.63 K
Book Value Per Share
3.14
0.15
1.28
5.38
2.77
4.76
2.79
2.27
4.19
-0.069
Current Liabilities
N/A
N/A
N/A
N/A
16.6 M
N/A
N/A
N/A
N/A
N/A
Total Asset
1.06 B
4.07 M
115.73 M
138.26 M
452.39 M
251.64 M
127.42 M
132.74 M
138.74 M
188.79 M
Debt To Equity
0.32
N/A
0.15
N/A
0.066
N/A
0.008
0.001
N/A
N/A
Short Ratio
1.16
1.94
0.33
15.38
12.16
6.29
1.11
3.16
0.82
1.88
Target Price
24.03
6.0
10.54
21.56
54.36
32.57
2.33
13.0
2.67
12.17
Shares Owned By Institutions
88.22
28.18
25.54
75.97
98.27
97.4
99.98
64.24
52.31
3.57
Market Capitalization
5.52 B
42.79 M
108.46 M
234.14 M
764.37 M
652.47 M
76.23 M
292.03 M
40.93 M
543.93 M
Price To Earning
163.51
N/A
N/A
N/A
81.21
N/A
0.64
N/A
3.96
N/A
Price To Sales
14.54
N/A
125.36
N/A
13.37
N/A
N/A
N/A
N/A
2077.17
Net Income
(10.1 M)
(8.2 M)
(18.95 M)
(60.39 M)
(163.62 M)
(71.9 M)
(75.52 M)
(68.46 M)
(64.73 M)
(220.24 M)
Earnings Per Share
0.01
-0.32
-0.72
-2.66
-6.05
-3.31
-2.99
-1.27
-1.99
-2.76
Shares Owned By Insiders
6.44
64.22
10.65
22.38
1.73
2.6
0.018
13.74
21.63
N/A
Revenue
361.7 M
N/A
18.11 M
N/A
17.16 M
N/A
N/A
N/A
N/A
124.67 K
Working Capital
53.6 M
3.25 M
81.99 M
116.39 M
369.39 M
238.62 M
106.59 M
119.05 M
96.46 M
124.14 M
Cash And Equivalents
109.6 M
14.55 M
168.04 M
N/A
442.15 M
N/A
151.99 M
150.41 M
113.39 M
44.63 M
Cash Per Share
0.48
0.62
3.87
N/A
15.66
N/A
6.22
3.87
5.84
1.01
Gross Profit
270.5 M
N/A
10.18 M
N/A
(78.51 M)
N/A
N/A
N/A
N/A
218.45 K
Day Typical Price
23.88
1.44
2.33
7.61
25.06
12.88
2.63
5.01
1.61
3.56
Accumulation Distribution
0.0404
34.24
34.21
341.45
8946.56
4097.76
2409.68
9059.88
164813.0
2369.59
Market Facilitation Index
0.99
0.0
0.0
0.0
0.0
0.0
0.0
0.0
N/A
0.0
Daily Balance Of Power
(0.57)
1.0
0.75
0.4615
(0.14)
(0.65)
(0.17)
0.2083
1.428571
0.9474
Period Momentum Indicator
(0.56)
0.01
0.03
0.06
(0.16)
(0.34)
(0.01)
0.05
0.3
0.36
Rate Of Daily Change
0.98
1.01
1.01
1.01
0.99
0.97
1.0
1.01
1.22
1.11
Day Median Price
24.03
1.44
2.32
7.63
25.11
12.94
2.63
4.99
1.58
3.5
Price Action Indicator
(0.71)
0.01
0.035
(0.01)
(0.23)
(0.34)
(0.01)
0.075
0.24
0.37
Relative Strength Index
71.69
39.31
40.78
68.93
26.39
54.81
69.28
58.17
62.52
38.9
Coefficient Of Variation
533.44
(198,551)
(5,534)
(1,949)
(1,207)
2542.3
609.01
2121.95
653.11
1042.81
Mean Deviation
2.25
4.86
4.38
2.87
3.46
2.71
2.44
2.76
2.25
3.21
Jensen Alpha
0.8296
(0.19)
(0.15)
(0.45)
(0.86)
(0.16)
0.4531
0.0066
0.5488
0.255
Total Risk Alpha
0.063
(1.48)
(1.15)
(0.93)
(1.32)
(0.50)
(0.02)
(0.51)
(0.07)
(0.33)
Sortino Ratio
0.24
N/A
N/A
N/A
N/A
0.0034
0.1782
0.018
0.1941
0.0695
Downside Variance
4.85
N/A
N/A
N/A
N/A
13.01
6.35
11.24
7.87
18.28
Standard Deviation
3.55
8.8
6.14
4.21
5.26
3.81
3.57
4.2
4.46
4.53
Kurtosis
8.2
14.67
2.13
1.64
10.72
2.09
4.32
10.42
15.97
1.26
Potential Upside
6.14
8.61
8.13
7.66
5.77
6.27
5.58
6.8
6.0
9.15
Treynor Ratio
(0.48)
(0.01)
(0.54)
(0.13)
(0.14)
0.0599
0.5955
0.1323
0.6952
0.3193
Maximum Drawdown
24.49
76.0
37.93
22.84
35.57
20.98
19.11
30.01
28.03
24.2
Variance
12.63
77.52
37.75
17.73
27.68
14.5
12.77
17.67
19.85
20.56
Market Risk Adjusted Performance
(0.47)
(0.0004)
(0.53)
(0.12)
(0.13)
0.0699
0.6055
0.1423
0.7052
0.3293
Risk Adjusted Performance
0.1512
0.0087
(0.01)
(0.03)
(0.05)
0.0381
0.1334
0.0442
0.1253
0.0816
Skewness
2.14
1.95
(0.64)
(0.23)
(1.99)
0.5197
1.57
2.17
3.57
0.3015
Semi Deviation
1.76
N/A
N/A
N/A
N/A
3.42
2.04
3.12
1.69
3.83
Information Ratio
0.1488
(0.02)
(0.04)
(0.08)
(0.11)
0.0032
0.1257
0.0144
0.1222
0.0655
Value At Risk
(3.03)
(11.48)
(9.52)
(7.65)
(7.28)
(5.79)
(3.86)
(5.54)
(2.83)
(7.49)
Expected Short fall
(2.90)
N/A
N/A
N/A
N/A
(2.78)
(3.35)
(3.14)
(3.91)
(3.73)
Downside Deviation
2.2
N/A
N/A
N/A
N/A
3.61
2.52
3.35
2.81
4.28
Semi Variance
3.1
N/A
N/A
N/A
N/A
11.67
4.14
9.72
2.86
14.71

Abcam PLC Competition Performance Charts

Five steps to successful analysis of Abcam PLC Competition

Abcam PLC's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Abcam PLC in relation to its competition. Abcam PLC's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Abcam PLC in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Abcam PLC's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Abcam PLC, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Abcam PLC position

In addition to having Abcam PLC in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Alternative Currency ETFs Thematic Idea Now

Alternative Currency ETFs
Alternative Currency ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Alternative Currency ETFs theme has 48 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Alternative Currency ETFs Theme or any other thematic opportunities.
View All  Next Launch
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Consideration for investing in Abcam Stock

If you are still planning to invest in Abcam PLC check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Abcam PLC's history and understand the potential risks before investing.
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY